By Bill Berkrot / Reuters NEW YORK: As drug counterfeiters step up their sales of bogus medicines, global health regulators have few protections in place to prevent them from reaching patients, and new laws aimed at addressing the problem could be years away. Scrutiny of the supply chain has grown since fake versions of Roche’s multibillion-dollar …
By Edmund Blair / Reuters CAIRO: Fake versions of the multibillion-dollar cancer drug Avastin were purchased in Turkey before being traded by middlemen across the Middle East and Europe to the United States, an Egyptian businessman involved said on Tuesday. Milad Kamal Ayad, who works on commission for Egyptian firm SAWA, told Reuters he sourced 167 …
By Edmund Blair / Reuters CAIRO: The trail of counterfeit copies of the multibillion-dollar cancer drug Avastin leads to an address in a crowded Cairo suburb, with no sign of the firm named by international suppliers as the source of the product. Last week’s discovery in the United States of the fake Avastin — containing no …
